Your Source for Global Health Insights
Explore the latest in pharmaceutical news, clinical trials, and vaccine innovation with our expert articles and reports.
Homepage News
Next-Gen mRNA & Oncology: 2026 FDA Deadline Approaches
April 6, 2026
Next-gen mRNA oncology faces August 2026 FDA deadline...
Foundayo Approval: Oral GLP-1 Obesity Paradigm Shift
April 3, 2026
Foundayo's oral GLP-1 approval shifts obesity paradigm...
FDA Approves Foundayo: First NME Under National Priority
April 2, 2026
Foundayo approved: Fastest NME via priority voucher program...
FDA Approves First Gene Therapy for Severe LAD-I
April 2, 2026
FDA approves autologous gene therapy for severe LAD-I...
2026 mRNA Cancer Vaccine Breakthroughs: Clinical & Regulatory
April 2, 2026
mRNA cancer vaccines: promising clinical & regulatory future...
Stay Informed Today
Subscribe to our newsletter for daily updates on pharmaceutical innovations and health news.
Vaktsina Global Intelligence: 🚨Live Pharmaceutical Feed
-
Joint statement by the Government of the Democratic Republic of the Congo and WHO concerning the outbreak of Ebola disease caused by the Bundibugyo virus
Date: 2026-05-31
-
WHO urges governments to protect young people from addiction to tobacco and nicotine products
Date: 2026-05-29
-
Experts convened by WHO advise on candidate treatments and vaccines for Ebola disease caused by Bundibugyo virus
Date: 2026-05-28
-
Message by the WHO Director-General to the people of the Democratic Republic of the Congo
Date: 2026-05-28
-
Seventy-ninth World Health Assembly – Daily update: 23 May 2026
Date: 2026-05-23
Join Our Community of Health Professionals Today
At Vaktsina Global, we are committed to delivering the most relevant pharmaceutical news and insights for healthcare professionals around the world.




